Screening for latent tuberculosis in Norwegian health care workers: High frequency of discordant tuberculin skin test positive and interferon-gamma release assay negative results

BMC Public Health

Volumn 13, Issue 1, 2013, Pages

  Gran, Gerd ^a   Aßmus, Jörg ^a   Dyrhol Riise, Anne Ma ^a,b,c  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Health care workers; IGRA; Interferon gamma release assay; Low endemic country, Norway; Quantiferon; Screening; Tuberculosis

Indexed keywords

GAMMA INTERFERON; TUBERCULIN;

ADULT; BLOOD; CROSS-SECTIONAL STUDY; ENDEMIC DISEASE; FEMALE; HEALTH CARE PERSONNEL; HUMAN; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; MALE; MASS SCREENING; METABOLISM; MIDDLE AGED; NORWAY; OCCUPATIONAL DISEASES; PREVALENCE; PROCEDURES; RISK FACTOR; SKIN; STATISTICAL MODEL; TUBERCULIN TEST; YOUNG ADULT;

ADULT; CROSS-SECTIONAL STUDIES; ENDEMIC DISEASES; FEMALE; HEALTH PERSONNEL; HUMANS; INTERFERON-GAMMA; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; LOGISTIC MODELS; MALE; MASS SCREENING; MIDDLE AGED; NORWAY; OCCUPATIONAL DISEASES; PREVALENCE; RISK FACTORS; SKIN; TUBERCULIN; TUBERCULIN TEST; YOUNG ADULT;

EID: 84876073244     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-13-353     Document Type: Article

References (41)

1. Tuberculosis among health-care workers in low- and middle-income countries: a systematic review. Joshi R, Reingold AL, Menzies D, Pai M, PLoS Med 2006 3 12 494 10.1371/journal.pmed.0030494 17194191
2. Risk of tuberculosis infection and disease associated with work in health care settings. Menzies D, Joshi R, Pai M, Int J Tuberc Lung Dis 2007 11 593e605
3. Arnesen TM, Heldal E, Mannsåker T, Sandbu S, Rønning K, Eide KÅ Tuberculosis in Norway 2010-2011 Oslo: The Norwegian Institute of Public Health 2012 http://www.fhi.no/dokumenter/2a2afe07bf.pdf
4. The Norwegian Institute of Public Health. Forebygging og kontroll av tuberkulose, en veileder (Norwegian), Guidelines for prevention and control of tuberculosis Oslo: Nasjonalt Folkehelseinstitutt 2002 7 http://www.fhi.no/dav/ EC1BCA06C5.pdf
5. What does tuberculin reactivity after bacille Calmette- Guerin vaccination tell us? Menzies D, Clin Infect Dis 2000 31 Suppl 3 71 S74 11010826
6. Advances in the diagnosis and treatment of tuberculosis. Nahid P, Pai M, Hopewell PC, Proc Am Thorac Soc 2006 3 1 103 110 10.1513/pats.200511-119JH 16493157
7. New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis. Pai M, Kalantri S, Dheda K, Expert Rev Mol Diagn 2006 3 413 422
8. Specific immune-based diagnosis of tuberculosis. Andersen P, Munk ME, Pollock JM, Doherty TM, Lancet 2000 356 9235 1099 1104 10.1016/S0140-6736(00) 02742-2 11009160
9. Interferon-c release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Diel R, Goletti D, Ferrara G, Bothamley G, Cirillo D, Kampmann B, Lange C, Losi M, Markova R, Migliori GB, Nienhaus A, Ruhwald M, Wagner D, Zellweger JP, Huitric E, Sandgren A, Manissero D, Eur Respir J 2011 37 88 99 10.1183/09031936.00115110 21030451
10. European Centre for Disease Prevention and Control, Use of interferon-gamma release assays in support of TB diagnosis Stockholm: ECDC 2011
11. Guidelines for preventing the transmission of mycobacterium tuberculosis in health care settings, 2005. Jensen PA, Lambert LA, Iademarco MF, Ridzon R, CDC, MMWR Recomm Rep 2005 54 1 141 16382216
12. Tuberculosis: Clinical Diagnosis and Management of Tuberculosis, and Measures for Its Prevention and Control, National Collaborating Centre for Chronic Conditions (UK), Centre for Clinical Practice at NICE (UK) London: National Institute for Health and Clinical Excellence (UK) 2011
13. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Menzies D, Pai M, Comstock G, Ann Intern Med 2007 146 5 340 354 10.7326/0003-4819-146-5- 200703060-00006 17339619
14. New immunological blood based assays for detection of tuberculosis. A report from the Infectious Disease Control Register (Norwegian). Winje B, Oftung F, Mannsåker T, Dyrhol-Riise AM, MSIS-rapport 2007 35 10
15. Latent tuberculosis infection in healthcare workers-evaluation of an Interferon-gamma release assay. Nienhaus A, Loddenkemper R, Hauer B, Wolf N, Diel R, Pneumology 2007 61 4 219 223 10.1055/s-2007-959161
16. Detecting a low prevalence of latent tuberculosis among health care workers in Denmark detected by M. tuberculosis specific IFN-gamma whole-blood test. Soborg B, Andersen AB, Larsen HK, Weldingh K, Andersen P, Kofoed K, Ravn P, Scand J Infect Dis 2007 39 6-7 554 559 17577817
17. Rates of latent tuberculosis in health care staff in Russia. Drobniewski F, Balabanova Y, Zakamova E, Nikolayevskyy V, Fedorin I, PLoS Med 2007 4 2 55 10.1371/journal.pmed.0040055 17298167
18. Comparison of QuantiFERON-TB Gold In-Tube Test and tuberculin skin test for identification of latent Mycobacterium tuberculosis infection in healthcare staff and association between positive test results and known risk factors for infection. Vinton P, Mihrshahi S, Johnson P, Jenkin GA, Jolley D, Biggs BA, Infect Control Hosp Epidemiol 2009 3 215 221
19. Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers. Harada N, Nakajima Y, Higuchi K, Sekiya Y, Rothel J, Mori T, Infect Control Hosp Epidemiol 2006 27 5 442 448 10.1086/504358 16671023
20. Whole-blood interferon- gamma release assay for baseline tuberculosis screening of healthcare workers at a swiss university hospital. Stebler A, Iseli P, Muhlemann K, Bodmer T, Infect Control Hosp Epidemiol 2008 29 7 681 683 10.1086/588587 18624672
21. In-hospital contact investigation among health care workers after exposure to smear-negative tuberculosis. Ringshausen FC, Schlosser S, Nienhaus A, Schablon A, Schultze- Werninghaus G, Rohde G, J Occup Med Toxicol 2009 4 11 10.1186/1745-6673-4-11 19505310
22. Prevalence of Latent Tuberculosis Infection among Health Care Workers in a hospital for pulmonary diseases. Schablon A, Beckmann G, Harling M, Diel R, Nienhaus A, J Occup Med Toxicol 2009 4 1 10.1186/1745-6673-4-1 19134168
23. Use of interferon gamma-based assay to diagnose tuberculosis infection in health care workers after short term exposure. Storla DG, Kristiansen I, Oftung F, Korsvold GE, Gaupset M, Gran G, Øverby AK, Dyrhol-Riise AM, Bjune GA, BMC Infect Dis 2009 9 60 10.1186/1471-2334-9-60 19432995
24. Evaluation of the Interferon-gamma Release Assay in Healthcare Workers. Nienhaus A, Schablon A, Siano B, le Bacle C, Diel R, Int Arch Occup Environ Health 2008 81 3 295 300 17605033
25. Risk of latent TB infection in individuals employed in the healthcare sector in Germany: a multicentre prevalence study. Schablon A, Harling M, Diel R, Nienhaus A, BMC Infect Dis 2010 10 107 10.1186/1471-2334-10-107 20429957
26. The prevalence of latent tuberculosis infections among health-care workers-a three-country comparison. Nienhaus A, Schablon A, Tripodi D, Torres Costa J, Pneumologie 2011 12 726 729
27. Usefulness of QuantiFERON TB-2G, a diagnostic method for latent tuberculosis infection, in a contact investigation of health care workers. Kobashi Y, Obase Y, Fukuda M, Yoshida K, Miyashita N, Fujii M, Oka M, Intern Med 2007 46 1543 1549 10.2169/internalmedicine.46.0088 17878640
28. Comparison of the interferon- gamma release assay and the tuberculin skin test for contact investigation of tuberculosis in BCG-vaccinated health care workers. Lee SS, Liu YC, Huang TS, Chen YS, Tsai HC, Wann SR, Lin HH, Scand J Infect Dis 2008 40 5 373 380 10.1080/00365540701730743 18418798
29. Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review. Zwerling A, van den Hof S, Scholten J, Cobelens F, Menzies D, Pai M, Thorax 2012 67 1 62 70 10.1136/thx.2010.143180 21228420
30. Screening for tuberculosis infection among newly arrived asylum seekers: comparison of QuantiFERONTB Gold with tuberculin skin test. Winje BA, Oftung F, Korsvold GE, Mannsåker T, Jeppesen AS, Harstad I, Heier BT, Heldal E, BMC Infect Dis 2008 8 65 10.1186/1471-2334-8-65 18479508
31. School based screening for tuberculosis infection in Norway: comparison of positive tuberculin skin test with interferon-gamma release assay. Winje BA, Oftung F, Korsvold GE, Mannsåker T, Nesthus IL, Harstad I, Dyrhol-Riise AM, Heldal E, BMC Infect Diseases 2008 8 140 10.1186/1471-2334-8-140
32. Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-Tube assay in outpatients from a tuberculosis low-endemic country. Dyrhol-Riise AM, Gran G, Wenzel-Larsen T, Blomberg B, Gill HC, Mørkve O, BMC Infect Dis 2010 10 57 10.1186/1471-2334-10-57 20210999
33. Predictive values of QuantiFERON-TB Gold testing in screening for tuberculosis disease in asylum seekers. Harstad I, Winje BA, Heldal E, Oftung F, Jacobsen GW, Int J Tuberc Lung Dis 2010 9 1209 1211
34. Nasjonalt Folkehelseinstitutt. Veiledning om vaksinasjon for helsepersonell (Norwegian), Guidelines for vaccination of health care workers Oslo: Nasjonalt Folkehelseinstitutt 2008
35. TB Screening in Canadian Health Care Workers Using Interferon-Gamma Release Assays. Zwerling A, Cojocariu M, McIntosh F, Pietrangelo F, Behr MA, Schwartzman K, Benedetti A, Dendukuri N, Menzies D, Pai M, PLoS One 2012 7 8 43014 10.1371/journal.pone.0043014 22916197
36. Interferon-gamma release assays for the tuberculosis serial testing of health care workers: a systematic review. Ringshausen FC, Schablon A, Nienhaus A, J Occup Med Toxicol 2012 7 1 6 10.1186/1745-6673-7-6 22537915
37. Challenges of interferon-γ release assay conversions in serial testing of health-care workers in a TB control program. Fong KS, Tomford JW, Teixeira L, Fraser TG, van Duin D, Yen-Lieberman B, Gordon SM, Miranda C, Chest 2012 142 1 55 62 10.1378/chest.11-0992 22796839
38. Monthly follow-ups of interferon-γ release assays among healthcare workers in contact with patients with TB. Park JS, Lee JS, Kim MY, Lee CH, Yoon HI, Lee SM, Yoo CG, Kim YW, Han SK, Yim JJ, Chest 2012 142 6 461 468
39. IGRA Expert Committee; Centers for Disease Control and Prevention (CDC) Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection-United States. Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K, MMWR Recomm Rep 2010 59 RR-5 1 25 21160459
40. Systematic review of cost and cost-effectiveness of different TB-screening strategies. Nienhaus A, Schablon A, Costa JT, Diel R, BMC Heal Serv Res 2011 11 247 10.1186/1472-6963-11-247
41. Screening health care workers with interferon-γ release assay versus tuberculin skin test: impact on costs and adherence to testing (the SWITCH study). Wrighton-Smith P, Sneed L, Humphrey F, Tao X, Bernacki E, J Occup Environ Med 2012 54 7 806 815 10.1097/JOM.0b013e318254620f 22796924